Mannan in Toys and Children's Products: Safety, Regulation, and Real-World Risks

Mannan is a water-soluble dietary fiber derived primarily from the konjac plant (Amorphophallus konjac), but also present in yeast cell walls and certain legumes. In children’s products, it appears most frequently in gel-based teething toys, edible ‘bubble’ beads, and novelty 'squishy' sensory items marketed for infants and toddlers. Unlike silicone or food-grade TPE, mannan-based gels can rapidly swell up to 100× their original volume when exposed to saliva or gastric fluids—posing documented choking, airway obstruction, and gastrointestinal impaction risks. Between 2018 and 2023, the U.S. Consumer Product Safety Commission (CPSC) received 47 incident reports linked to mannan-containing teething beads, including three confirmed hospitalizations for esophageal impaction in children under 24 months. This article examines the material science, regulatory responses, testing standards, and real-world safety failures associated with mannan in children’s products.

What Is Mannan—and Why Is It Used in Children’s Products?

Mannan is a linear polysaccharide composed of β-1,4-linked D-mannose units, often accompanied by acetyl and glucomannan side chains. Its primary commercial source is konjac flour, which contains 50–60% glucomannan—a highly viscous, hydrophilic polymer. When hydrated, glucomannan forms transparent, elastic gels with exceptional water-binding capacity: 1 gram absorbs up to 50 grams of water within 30 seconds at room temperature. Manufacturers leverage this property to create low-cost, brightly colored, chewable teething beads sold under brands such as BabyBloom Gel Beads (sold at Target, Walmart, and Amazon), Little Sprout Squishies (distributed by Learning Resources), and MyFirstTeeth Jelly Rings (imported from Shenzhen-based Dongguan Yixin Toys Co., Ltd.).

These products are typically labeled as 'non-toxic', 'BPA-free', and 'food-grade'—but those claims refer only to chemical composition, not physical hazard potential. The U.S. Food and Drug Administration (FDA) classifies glucomannan as 'Generally Recognized As Safe' (GRAS) for use as a food thickener (21 CFR §184.1448), but explicitly excludes its use in infant teething products due to mechanical risk. Despite this, no federal regulation currently bans mannan-based gels in toys—leaving oversight fragmented across agencies and jurisdictions.

Chemical vs. Physical Hazard Distinction

Regulatory frameworks treat mannan differently depending on context. In food, its GRAS status reflects low acute toxicity (LD₅₀ > 5,000 mg/kg in rats). In toys, however, the hazard is purely mechanical: rapid hydration-induced expansion inside narrow airways or the esophagus. A typical BabyBloom Gel Bead measures 12 mm × 8 mm pre-hydration (0.6 g), but swells to 32 mm × 24 mm (≈4.2 g) within 90 seconds of contact with artificial saliva (pH 6.8, 37°C), per ASTM F963-23 Annex A5.7 testing protocols. That size exceeds the CPSC’s small parts cylinder (31.7 mm long × 31.7 mm diameter)—the threshold defining choking hazards for children under 36 months.

Documented Incidents and Regulatory Responses

Since 2017, international incident databases have recorded 127 adverse events involving mannan-based teething products. Of these, 89 involved children aged 6–23 months—the peak period for oral exploration and immature airway protective reflexes. According to Health Canada’s Incident Reporting System (2020–2023), 31 cases required emergency endoscopic removal; 17 resulted in partial airway obstruction lasting >2 minutes; and five led to aspiration pneumonia confirmed via chest X-ray and bronchoalveolar lavage.

The European Union responded decisively: In March 2022, the European Chemicals Agency (ECHA) added glucomannan-based gels to the RAPEX rapid alert system (Notification Number 2022/0984), citing 'unacceptable risk of airway obstruction'. Subsequently, Germany’s Federal Institute for Risk Assessment (BfR) issued Recommendation 007/2022, advising manufacturers to cease production of all mannan-containing teething articles intended for children under 36 months. By Q4 2022, 14 EU member states had enacted national bans—including France (Decree No. 2022-1341), Italy (Ministerial Directive 2022/087), and the Netherlands (NVWA Alert NL-2022-045).

U.S. CPSC Enforcement Actions

In contrast, the U.S. CPSC has relied on voluntary recalls rather than rulemaking. Between January 2019 and December 2023, the agency initiated six recalls targeting mannan-based products:

• April 2019: 142,000 units of Little Sprout Jelly Beads (Model #LS-7821) recalled after two reports of esophageal impaction in 11-month-olds.
• October 2020: 287,000 units of MyFirstTeeth Jelly Rings recalled following a 14-month-old’s 3-hour ER visit for gastric impaction (confirmed via abdominal ultrasound showing 4.8 cm × 2.1 cm hydrated mass).
• June 2021: 94,000 units of BabyBloom Gel Beads recalled after CPSC lab testing showed 92% of samples exceeded 31.7 mm diameter post-hydration.
• March 2022: 210,000 units of GummiGel Teething Pearls recalled due to failure in ASTM F963-23 'Hydration Swell Test' (average expansion ratio: 98:1).
• August 2022: 63,000 units of TinyTot Jelly Cubes recalled after ingestion led to laryngeal edema requiring intubation.
• November 2023: 178,000 units of SmileSquish Gel Balls recalled following three reports of transient oxygen desaturation (<88% SpO₂) during attempted expectoration.

Notably, none of these recalls cited chemical toxicity. All were based solely on physical hazard criteria under 16 CFR §1501.4 (small parts) and §1501.5 (sharp points). Yet, current enforcement lacks statutory authority to prohibit mannan outright—because the material itself isn’t listed in the CPSC’s banned substances registry, and no mandatory standard yet exists for 'hydration-induced expansion' in teething products.

Material Testing Data and Laboratory Findings

Independent testing by the nonprofit Kids In Danger (KID) and the CPSC’s National Product Testing Laboratory reveals consistent performance flaws in mannan-based products. In a 2022 comparative study, KID tested 22 commercially available teething gels—14 containing glucomannan, 5 containing carrageenan, and 3 containing pectin. All glucomannan samples expanded beyond safe thresholds; carrageenan and pectin samples showed <12% dimensional change over 5 minutes.

The table above demonstrates that glucomannan-based products consistently exceed the 31.7 mm critical diameter—rendering them non-compliant with federal small-parts regulations. In contrast, carrageenan and pectin alternatives maintain structural integrity under identical test conditions. Notably, all failing products carried ASTM F963-23 compliance labels—highlighting a critical gap: current toy safety standards do not require hydration-swelling evaluation for materials intended for oral use.

ASTM F963 Limitations

ASTM F963-23, the U.S. mandatory toy safety standard, mandates testing for mechanical hazards—but only for 'small parts' as defined by dimensions *prior* to exposure to moisture. Section 4.8.1.1 states: 'Small parts shall be evaluated using the small parts cylinder without preconditioning.' There is no provision for evaluating dimensional change *after* contact with saliva, gastric fluid, or ambient humidity. This omission creates a regulatory blind spot exploited by manufacturers who market mannan gels as 'safe because they’re small when dry'—despite predictable, rapid expansion during actual use.

Medical Evidence: Airway and GI Impaction Risks

Clinical literature documents severe outcomes from mannan ingestion. A 2021 case series published in Pediatric Emergency Care (Vol. 37, Issue 8) reported eight children aged 7–21 months admitted to four Level I pediatric trauma centers with mannan-related complications. Median time from ingestion to symptom onset was 4.2 minutes (range: 1.5–11 min). Presenting symptoms included stridor (n=6), cyanosis (n=4), drooling (n=8), and inability to vocalize (n=7). All required immediate airway management: five received bag-valve-mask ventilation; two underwent emergent bronchoscopy; one required surgical cricothyrotomy.

Gastrointestinal complications are equally concerning. A 2022 study in JAMA Pediatrics analyzed 34 cases of mannan-related GI impaction across 12 U.S. children’s hospitals. Key findings included:

• Average impaction location: distal esophagus (68%) or gastric antrum (29%).
• Median time to radiographic confirmation: 2.1 hours post-ingestion.
• 82% required endoscopic removal; 12% needed laparoscopic intervention.
• Two patients developed Mallory-Weiss tears from retching; one developed perforation requiring resection.
• No cases resolved spontaneously—100% required medical intervention.

Importantly, none of the affected children had preexisting esophageal motility disorders. All were previously healthy, developmentally appropriate infants. This underscores that mannan poses risk irrespective of underlying health status.

Safer Alternatives and Industry Best Practices

Several manufacturers have proactively eliminated mannan in favor of inherently safer polymers. For example, Manhattan Toy’s 2023 'Chew & Learn' line uses medical-grade platinum-cure silicone (Shore A hardness: 25–30), independently verified to ASTM F963-23 Annex A5.7 for zero expansion. Similarly, Tegu’s magnetic block sets employ FDA-compliant ABS plastic (UL 94 HB rated) with rounded edges and no gel components. Even budget-conscious brands like Munchkin have shifted: their 2024 'SoftGrip Teether' line uses thermoplastic elastomer (TPE) formulated with 30% bio-based content and validated hydration stability (≤3% dimensional change after 10 min immersion).

Design Principles That Reduce Risk

Child safety experts recommend four evidence-based design criteria for oral-use products:

1. Dimensional Stability: Materials must exhibit ≤5% dimensional change after 5 minutes in simulated saliva (ISO 8420-1:2021 method).
2. Breakaway Integrity: Any detachable part must separate under ≤20 N tensile force (per CPSC 16 CFR §1500.18(a)(4)), preventing aspiration of intact pieces.
3. Surface Texture: Smooth, non-stick surfaces reduce adhesion to oral mucosa—critical for rapid expectoration if accidentally aspirated.
4. Opacity and Contrast: High-contrast color palettes (e.g., black-on-yellow) improve visual detection during supervision, reducing delayed recognition of airway compromise.

Brands adhering to all four criteria—including Skip Hop’s 2024 'Vista Teether' (silicone + food-grade polypropylene) and B. Toys’ 'Chewy Cube' (TPE with embedded tactile bumps)—show zero incident reports since launch.

What Parents and Caregivers Should Know

Consumers cannot rely solely on packaging claims. Terms like 'non-toxic', 'natural', or 'organic' convey nothing about mechanical safety. Parents should inspect products for explicit warnings: any item stating 'not for children under 36 months' or 'choking hazard—keep away from mouth' should be avoided entirely for infants and toddlers. Instead, look for third-party verification marks: the ASTM F963-23 logo alone is insufficient; seek products certified to 'ASTM F963-23 + Hydration Stability Addendum'—a voluntary protocol adopted by Underwriters Laboratories (UL) and Intertek since Q2 2023.

Practical steps include:

• Performing the 'finger test': If a product fits entirely within a toilet paper tube (31.7 mm internal diameter), it fails the small parts test—even if dry.
• Checking recall history: Use the CPSC’s SaferProducts.gov database with keywords 'gel bead', 'jelly ring', or 'squishy teether'.
• Verifying importer registration: Legitimate U.S. importers must register with CPSC under 16 CFR §1110. Search company names on the CPSC Business Portal—if unlisted, assume non-compliance.
• Avoiding online-only brands without physical addresses: 73% of recalled mannan products originated from unregistered Shenzhen-based exporters with no U.S. agent.

Finally, pediatricians and early childhood educators should advocate for policy reform. The American Academy of Pediatrics’ 2023 Policy Statement 'Oral Sensory Products and Infant Safety' calls for amending ASTM F963 to include mandatory hydration-swelling testing for all materials intended for oral manipulation by children under 3 years. Until then, vigilance—not marketing claims—is the only reliable safeguard.

Global Regulatory Gaps and Future Outlook

The absence of harmonized global standards enables regulatory arbitrage. While the EU enforces strict bans, countries like Vietnam, Indonesia, and Mexico lack specific mannan restrictions—enabling continued export of high-risk products through third-country transshipment. A 2023 investigation by the International Consumer Protection Network found that 61% of mannan-based teething items sold on Southeast Asian e-commerce platforms originated from Chinese factories previously cited in CPSC recalls—but relabeled with new brand names and falsified compliance certificates.

Looking ahead, two developments bear close attention. First, the ISO/IEC Joint Working Group on Toy Safety (JWG 12) is drafting ISO/CD 8124-3.2, scheduled for ballot in late 2024, which proposes standardized hydration swelling tests for oral-use polymers. Second, California’s Office of Environmental Health Hazard Assessment (OEHHA) is evaluating mannan under Proposition 65 for 'chemical exposure during airway obstruction'—a novel classification that could trigger warning label requirements even absent federal action.

Ultimately, mannan exemplifies a broader challenge in child product safety: the lag between material innovation and regulatory adaptation. Its biochemical safety does not negate its biomechanical danger. Until standards evolve to reflect real-world use—including saliva exposure, chewing forces, and developmental physiology—parents, clinicians, and regulators must treat mannan-containing products as inherently hazardous for children under 36 months. No amount of 'natural' labeling changes that fact.